NCT02078648 2025-02-03Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeStemline Therapeutics, Inc.Phase 1/2 Completed74 enrolled 19 charts
NCT01920191 2016-04-20Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in GlioblastomaUniversity Hospital, GenevaPhase 1/2 Completed19 enrolled